Literature DB >> 22561333

Comparative toxicogenomic analysis of oral Cr(VI) exposure effects in rat and mouse small intestinal epithelia.

Anna K Kopec1, Chad M Thompson, Suntae Kim, Agnes L Forgacs, Timothy R Zacharewski.   

Abstract

Continuous exposure to high concentrations of hexavalent chromium [Cr(VI)] in drinking water results in intestinal tumors in mice but not rats. Concentration-dependent gene expression effects were evaluated in female F344 rat duodenal and jejunal epithelia following 7 and 90 days of exposure to 0.3-520 mg/L (as sodium dichromate dihydrate, SDD) in drinking water. Whole-genome microarrays identified 3269 and 1815 duodenal, and 4557 and 1534 jejunal differentially expressed genes at 8 and 91 days, respectively, with significant overlaps between the intestinal segments. Functional annotation identified gene expression changes associated with oxidative stress, cell cycle, cell death, and immune response that were consistent with reported changes in redox status and histopathology. Comparative analysis with B6C3F1 mouse data from a similarly designed study identified 2790 differentially expressed rat orthologs in the duodenum compared to 5013 mouse orthologs at day 8, and only 1504 rat and 3484 mouse orthologs at day 91. Automated dose-response modeling resulted in similar median EC₅₀s in the rodent duodenal and jejunal mucosae. Comparative examination of differentially expressed genes also identified divergently regulated orthologs. Comparable numbers of differentially expressed genes were observed at equivalent Cr concentrations (μg Cr/g duodenum). However, mice accumulated higher Cr levels than rats at ≥ 170 mg/L SDD, resulting in a ~2-fold increase in the number of differentially expressed genes. These qualitative and quantitative differences in differential gene expression, which correlate with differences in tissue dose, likely contribute to the disparate intestinal tumor outcomes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561333     DOI: 10.1016/j.taap.2012.04.026

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  Systematic evaluation of medium-throughput mRNA abundance platforms.

Authors:  Stephenie D Prokopec; John D Watson; Daryl M Waggott; Ashley B Smith; Alexander H Wu; Allan B Okey; Raimo Pohjanvirta; Paul C Boutros
Journal:  RNA       Date:  2012-11-20       Impact factor: 4.942

Review 2.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

3.  Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics.

Authors:  Michal W Luczak; Samantha E Green; Anatoly Zhitkovich
Journal:  Environ Health Perspect       Date:  2015-05-15       Impact factor: 9.031

4.  Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): Implications for risk assessment.

Authors:  Chad M Thompson; Julia E Rager; Mina Suh; Caroline L Ring; Deborah M Proctor; Laurie C Haws; Rebecca C Fry; Mark A Harris
Journal:  Environ Mol Mutagen       Date:  2016-11-15       Impact factor: 3.216

5.  High-Throughput Screening Data Interpretation in the Context of In Vivo Transcriptomic Responses to Oral Cr(VI) Exposure.

Authors:  Julia E Rager; Caroline L Ring; Rebecca C Fry; Mina Suh; Deborah M Proctor; Laurie C Haws; Mark A Harris; Chad M Thompson
Journal:  Toxicol Sci       Date:  2017-07-01       Impact factor: 4.849

6.  Particulate Hexavalent Chromium Inhibits E2F1 Leading to Reduced RAD51 Nuclear Foci Formation in Human Lung Cells.

Authors:  Rachel M Speer; Jennifer H Toyoda; Tayler J Croom-Perez; Ke Jian Liu; John Pierce Wise
Journal:  Toxicol Sci       Date:  2021-04-27       Impact factor: 4.849

7.  Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysis.

Authors:  Chad M Thompson; Yuriy Fedorov; Daniel D Brown; Mina Suh; Deborah M Proctor; Liz Kuriakose; Laurie C Haws; Mark A Harris
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

8.  A chronic oral reference dose for hexavalent chromium-induced intestinal cancer.

Authors:  Chad M Thompson; Christopher R Kirman; Deborah M Proctor; Laurie C Haws; Mina Suh; Sean M Hays; J Gregory Hixon; Mark A Harris
Journal:  J Appl Toxicol       Date:  2013-08-14       Impact factor: 3.446

9.  Reevaluation and Classification of Duodenal Lesions in B6C3F1 Mice and F344 Rats from 4 Studies of Hexavalent Chromium in Drinking Water.

Authors:  John M Cullen; Jerrold M Ward; Chad M Thompson
Journal:  Toxicol Pathol       Date:  2015-11-04       Impact factor: 1.902

10.  Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium.

Authors:  Chad M Thompson; Christopher R Kirman; Sean M Hays; Mina Suh; Seneca E Harvey; Deborah M Proctor; Julia E Rager; Laurie C Haws; Mark A Harris
Journal:  J Appl Toxicol       Date:  2017-10-24       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.